• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRC2与SWI/SNF染色质重塑复合体在健康与疾病中的作用

PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease.

作者信息

Kadoch Cigall, Copeland Robert A, Keilhack Heike

机构信息

Dana-Farber Cancer Institute and Harvard Medical School , 450 Brookline Avenue, Boston, Massachusetts 02215, United States.

Epizyme Inc. , 400 Technology Square, 4th floor, Cambridge, Massachusetts 02139, United States.

出版信息

Biochemistry. 2016 Mar 22;55(11):1600-14. doi: 10.1021/acs.biochem.5b01191. Epub 2016 Feb 17.

DOI:10.1021/acs.biochem.5b01191
PMID:26836503
Abstract

The dynamic structure of histones and DNA, also known as chromatin, is regulated by two classes of enzymes: those that mediate covalent modifications on either histone proteins or DNA and those that use the energy generated by ATP hydrolysis to mechanically alter chromatic structure. Both classes of enzymes are often found in large protein complexes. In this review, we describe two such complexes: polycomb repressive complex 2 (PRC2), with the protein methyltransferase EZH2 as its catalytic subunit, and the ATP-dependent chromatin remodeler switch/sucrose non-fermentable (SWI/SNF). EZH2 catalyzes the methylation of lysine 27 on histone H3, a covalent chromatin modification that is associated with repressed heterochromatin. The catalytic activity of SWI/SNF, in contrast, leads to a state of open chromatin associated with active transcription. In this review, we discuss the biochemical properties of both complexes, outline the principles of their regulation, and describe their opposing roles in normal development, which can be perturbed in disease settings such as cancer.

摘要

组蛋白和DNA的动态结构,也称为染色质,由两类酶调控:一类是介导组蛋白或DNA共价修饰的酶,另一类是利用ATP水解产生的能量机械改变染色质结构的酶。这两类酶通常都存在于大型蛋白质复合物中。在本综述中,我们描述了两种这样的复合物:多梳抑制复合物2(PRC2),其催化亚基为蛋白质甲基转移酶EZH2,以及ATP依赖的染色质重塑因子开关/蔗糖不发酵复合物(SWI/SNF)。EZH2催化组蛋白H3上赖氨酸27的甲基化,这是一种与抑制性异染色质相关的共价染色质修饰。相比之下,SWI/SNF的催化活性会导致与活跃转录相关的开放染色质状态。在本综述中,我们讨论了这两种复合物的生化特性,概述了它们的调控原则,并描述了它们在正常发育中的相反作用,而在癌症等疾病环境中这些作用可能会受到干扰。

相似文献

1
PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease.PRC2与SWI/SNF染色质重塑复合体在健康与疾病中的作用
Biochemistry. 2016 Mar 22;55(11):1600-14. doi: 10.1021/acs.biochem.5b01191. Epub 2016 Feb 17.
2
SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.SWI/SNF 突变型癌症依赖于 EZH2 的催化活性和非催化活性。
Nat Med. 2015 Dec;21(12):1491-6. doi: 10.1038/nm.3968. Epub 2015 Nov 9.
3
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.EZH2抑制在滑膜肉瘤人源模型中诱导抗肿瘤活性的临床前证据
PLoS One. 2016 Jul 8;11(7):e0158888. doi: 10.1371/journal.pone.0158888. eCollection 2016.
4
Genome-wide occupancy of Arabidopsis SWI/SNF chromatin remodeler SPLAYED provides insights into its interplay with its close homolog BRAHMA and Polycomb proteins.拟南芥SWI/SNF染色质重塑因子SPLAYED的全基因组占据情况为其与紧密同源物BRAHMA和多梳蛋白的相互作用提供了见解。
Plant J. 2021 Apr;106(1):200-213. doi: 10.1111/tpj.15159. Epub 2021 Mar 17.
5
Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer.危险的勾结:SWI/SNF、NuRD 和 Polycomb 在染色质调控和癌症中的相互作用。
Genes Dev. 2019 Aug 1;33(15-16):936-959. doi: 10.1101/gad.326066.119. Epub 2019 May 23.
6
The role of EZH1 and EZH2 in development and cancer.EZH1 和 EZH2 在发育和癌症中的作用。
BMB Rep. 2022 Dec;55(12):595-601. doi: 10.5483/BMBRep.2022.55.12.174.
7
Inner workings and regulatory inputs that control Polycomb repressive complex 2.控制多梳抑制复合体2的内部机制和调控输入。
Chromosoma. 2012 Jun;121(3):221-34. doi: 10.1007/s00412-012-0361-1. Epub 2012 Feb 19.
8
Polycomb Repressive Complex 2 in Oncology.多梳抑制复合物 2 在肿瘤学中的作用。
Cancer Treat Res. 2023;190:273-320. doi: 10.1007/978-3-031-45654-1_9.
9
DOC1-Dependent Recruitment of NURD Reveals Antagonism with SWI/SNF during Epithelial-Mesenchymal Transition in Oral Cancer Cells.DOC1依赖性募集NURD揭示了口腔癌细胞上皮-间质转化过程中与SWI/SNF的拮抗作用。
Cell Rep. 2017 Jul 5;20(1):61-75. doi: 10.1016/j.celrep.2017.06.020.
10
PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.PRC2 介导的 SMARCA2 抑制预测 EZH2 抑制剂在 SWI/SNF 突变型肿瘤中的活性。
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):12249-12254. doi: 10.1073/pnas.1703966114. Epub 2017 Oct 30.

引用本文的文献

1
Mutual Antagonism Between PRC1 Condensates and SWI/SNF in Chromatin Regulation.PRC1凝聚体与SWI/SNF在染色质调控中的相互拮抗作用。
bioRxiv. 2025 Aug 26:2025.08.25.672128. doi: 10.1101/2025.08.25.672128.
2
Transcriptomic Comparisons of Somatic and Cancer Stem Cells.体细胞与癌症干细胞的转录组比较
Biomedicines. 2025 Aug 21;13(8):2039. doi: 10.3390/biomedicines13082039.
3
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study.
新型EZH1/2双重抑制剂HH2853在难治性实体瘤或非霍奇金淋巴瘤患者中的安全性和有效性:一项I期研究
EClinicalMedicine. 2025 Aug 7;86:103398. doi: 10.1016/j.eclinm.2025.103398. eCollection 2025 Aug.
4
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.儿童非横纹肌肉瘤软组织肉瘤中进一步研究新型药物的优先级排序:来自儿童肿瘤协作组的报告
Eur J Cancer. 2025 Aug 26;226:115600. doi: 10.1016/j.ejca.2025.115600. Epub 2025 Jul 6.
5
Acetylation-Mediated Epigenetic Consequences for Biological Control and Cancer.乙酰化介导的生物调控与癌症的表观遗传学后果
Results Probl Cell Differ. 2025;75:25-69. doi: 10.1007/978-3-031-91459-1_2.
6
Structural analysis of the lncRNA SChLAP1 reveals protein binding interfaces and a conformationally heterogenous retroviral insertion.lncRNA SChLAP1的结构分析揭示了蛋白质结合界面和构象异质性逆转录病毒插入。
RNA. 2025 Aug 18;31(9):1260-1286. doi: 10.1261/rna.080488.125.
7
Dual targeting of CXCR4 and EZH2 in endometriosis.子宫内膜异位症中CXCR4和EZH2的双重靶向作用
iScience. 2025 Mar 1;28(4):112143. doi: 10.1016/j.isci.2025.112143. eCollection 2025 Apr 18.
8
Hypermethylation of CDKN2A CpG island drives resistance to PRC2 inhibitors in SWI/SNF loss-of-function tumors.CDKN2A CpG 岛的超甲基化导致 SWI/SNF 功能丧失型肿瘤对 PRC2 抑制剂产生耐药性。
Cell Death Dis. 2024 Nov 5;15(11):794. doi: 10.1038/s41419-024-07109-3.
9
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.SMARCB1 表达缺失是人类和鼠外周 T 细胞淋巴瘤的一个亚型的特征。
Nat Commun. 2024 Oct 3;15(1):8571. doi: 10.1038/s41467-024-52826-0.
10
Genome-Wide CRISPR Screen Identifies KEAP1 Perturbation as a Vulnerability of ARID1A-Deficient Cells.全基因组CRISPR筛选确定KEAP1扰动是ARID1A缺陷细胞的一个脆弱点。
Cancers (Basel). 2024 Aug 24;16(17):2949. doi: 10.3390/cancers16172949.